SCHEMBL7407207

SCHEMBL7407207

O=C(O)CC(Cc1ccc(-c2ccccc2)cc1)NC(c1ccccc1)(c1ccccc1)P(=O)(O)O

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MME P08473 11/20 0.48
MMEL1 Q495T6 8/20 0.48
ACP3 P15309 2/20 0.44
ACE P12821 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7407197 1.00 MME (0.48) MMEMMEL1ACP3ACE
SCHEMBL7407909 0.88 MME (0.57) MMEMMEL1ACE
SCHEMBL7407921 0.88 MME (0.57) MMEMMEL1ACE
SCHEMBL7415381 0.85 MMEL1 (0.50) MMEMMEL1ACP3ACE
SCHEMBL7415374 0.85 MMEL1 (0.50) MMEMMEL1ACP3ACE
SCHEMBL7407171 0.83 MME (0.50) MMEACP3ACE
SCHEMBL7407179 0.83 MME (0.50) MMEACP3ACE
SCHEMBL7310766 0.80 MME (0.48) MMEMMEL1ACE
SCHEMBL7310740 0.80 MME (0.48) MMEMMEL1ACE
SCHEMBL7309981 0.78 MMEL1 (0.59) MMEMMEL1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660840-B1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
WO-1996026729-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES AS ECE INHIBITORS CIBA-GEIGY AG (CH) 1996-09-06 WO disclosed
US-5550119-A ENDOTHELIN-CONVERTING ENZYM INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-08-27 US disclosed
EP-0660840-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES. CIBA GEIGY AG (CH) 1995-07-05 EP disclosed
WO-1994005677-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA-GEIGY AG (CH) 1994-03-17 WO disclosed
US-5250522-A Neutral endopeptidase inhibitors; cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1993-10-05 US disclosed